News
US Plans to Test Medicare, Medicaid Coverage for Weight-Loss Drugs, Washington Post Reports
According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits coverage of the drugs used solely for weight loss, but allows for treating indications they are approved for like sleep apnea and heart disease.
GLP‑1 receptor agonists are widely recognized for aiding weight loss and controlling blood sugar, but access remains limited — especially for Medicare and Medicaid patients. That might change with a ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.
The government’s five‑year experiment could be the first step toward broad public coverage of GLP‑1 drugs. If a new experiment pans out, Medicaid and Medicare could begin covering the costly ...
Straight Arrow News on MSN20d
New study links obesity to diet, not lack of exercise
For decades, conventional wisdom has blamed obesity on inactivity. But a new study published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) challenges ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback